Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trial
阿特珠单抗对比化疗治疗伴有高血源性肿瘤突变负荷的晚期或转移性非小细胞肺癌:BFAST C队列随机3期试验的主要分析
期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-022-01933-w
Peters, Solange; Dziadziuszko, Rafal; Morabito, Alessandro; Felip, Enriqueta; Gadgeel, Shirish M; Cheema, Parneet; Cobo, Manuel; Andric, Zoran; Barrios, Carlos H; Yamaguchi, Masafumi; Dansin, Eric; Danchaivijitr, Pongwut; Johnson, Melissa; Novello, Silvia; Mathisen, Michael S; Shagan, Sarah M; Schleifman, Erica; Wang, Jin; Yan, Mark; Mocci, Simonetta; Voong, David; Fabrizio, David A; Shames, David S; Riehl, Todd; Gandara, David R; Mok, Tony